Company: HCTI
Filing Date: 2025-10-02
Form Type: PRE 14C
Source: 0001213900-25-095494
Chunk: 0

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-02
Form: PRE 14C
Chunk 0
---
<div align='center'>UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14C
(Rule 14c-101)

SCHEDULE 14C INFORMATION

Information Statement Pursuant to Section 14(c) of the Securities
Exchange Act of 1934 (Amendment No. ____)</div>

Check the appropriate box:

| ☒ | Preliminary Information Statement                                               |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) |
| ☐ | Definitive Information Statement                                                |

<div align='center'>HEALTHCARE TRIANGLE, INC.(Name of Registrant as Specified In Its Charter)</div>

Payment of Filing Fee (Check all boxes that apply):

| ☒ | No fee required.                                                                                        |
| ☐ | Fee paid previously with preliminary materials.                                                         |
| ☐ | Fee computed on table below in exhibit required by Item 25(b) Exchange Act Rules 14a-6(i)(14) and 0-11. |

<div align='center'>PRELIMINARY INFORMATION STATEMENT

NOTICE OF STOCKHOLDER ACTION BY WRITTEN CONSENT

WE ARE NOT ASKING YOU FOR A PROXY, AND YOU ARE REQUESTED NOT TO SEND US
A PROXY. NO PROXY CARD HAS BEEN ENCLOSED WITH THIS INFORMATION STATEMENT.</div>

Dear Stockholders:

This Information Statement is first being mailed
on or about October [*], 2025 to the stockholders of record of the outstanding shares of common stock of Healthcare Triangle, Inc., a
Delaware corporation (“Healthcare Triangle,” the “Company,” “we,” “our,”
or “us”) as of the close of business on September 19, 2025 (the “Record Date”), pursuant to Rule 14c-2 promulgated
under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The purpose of this Information Statement
is to inform our stockholders of actions taken by written consent of Suresh Venkatachari, the holder of 81.82% of our voting power (the
“Majority Stockholder”). This Information Statement is being sent to you for informational purposes only and shall
be considered the notice required under Rule 14c-2 of the Exchange Act and Section 228(e) of the Delaware General Corporation Law (“GCL”).

The